首页 > 最新文献

European Journal of Anaesthesiology最新文献

英文 中文
A survey and analysis of peri-operative quality indicators promoted by National Societies of Anaesthesiologists in Europe: The EQUIP project. 欧洲各国麻醉医师协会推广的围手术期质量指标调查与分析:EQUIP 项目。
IF 3.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-12 DOI: 10.1097/eja.0000000000002054
Johannes Wacker,Guy Haller,Jan F A Hendrickx,Martin Ponschab
BACKGROUNDTo capture preventable peri-operative patient harm and guide improvement initiatives, many quality indicators (QIs) have been developed. Several National Anaesthesiologist Societies (NAS) in Europe have implemented quality indicators. To date, the definitions, validity and dissemination of such quality indicators, and their comparability with validated published indicators are unknown.OBJECTIVESThe aim of this study was to identify all quality indicators promoted by NAS in Europe, to assess their characteristics and to compare them with published validated quality indicators.DESIGNA cross-sectional study with mixed methods analysis. Using a survey questionnaire, representatives of 37 NAS were asked if their society provided quality indicators to their members and, if so, to provide the list, definitions and details of quality indicators. Characteristics of reported quality indicators were analysed.SETTINGThe 37 NAS affiliated with the European Society of Anaesthesiology and Intensive Care (ESAIC) at the time. Data collection, translations: March 2018 to February 2020.PARTICIPANTSRepresentatives of all 37 NAS completed the survey.MAIN OUTCOME MEASURESQIs reported by NAS.RESULTSOnly 12 (32%) of the 37 NAS had made a set of quality indicators available to their members. Data collection was mandatory in six (16.2%) of the 37 countries. We identified 163 individual quality indicators, which were most commonly descriptive (60.1%), anaesthesia-specific (50.3%) and related to intra-operative care (21.5%). They often measured structures (41.7%) and aspects of safety (35.6%), appropriateness (20.9%) and prevention (16.6%). Patient-centred care (3.7%) was not well covered. Only 11.7% of QIs corresponded to published validated or well established quality indicator sets.CONCLUSIONSFew NAS in Europe promoted peri-operative quality indicators. Most of them differed from published sets of validated indicators and were often related to the structural dimension of quality. There is a need to establish a European-wide comprehensive core set of usable and validated quality indicators to monitor the quality of peri-operative care.TRIAL REGISTRATIONNo registration.
背景为了掌握可预防的围手术期患者伤害并指导改进措施,已制定了许多质量指标(QIs)。欧洲的一些国家麻醉医师协会(NAS)已经实施了质量指标。本研究旨在确定欧洲国家麻醉师协会推广的所有质量指标,评估这些指标的特点,并将其与已公布的有效质量指标进行比较。通过调查问卷,询问了 37 个 NAS 的代表其协会是否向会员提供质量指标,如果提供,请提供质量指标的列表、定义和详细信息。对报告的质量指标的特点进行了分析。调查对象当时隶属于欧洲麻醉学和重症监护学会(ESAIC)的37个NAS。数据收集、翻译:结果37个NAS中只有12个(32%)向其成员提供了一套质量指标。在 37 个国家中,有 6 个国家(16.2%)强制要求收集数据。我们确定了 163 个质量指标,其中最常见的是描述性指标(60.1%)、麻醉专用指标(50.3%)以及与术中护理有关的指标(21.5%)。这些指标通常衡量结构(41.7%)、安全性(35.6%)、适当性(20.9%)和预防性(16.6%)。以病人为中心的护理(3.7%)没有得到很好的覆盖。只有 11.7% 的质量指标与已公布的有效或成熟的质量指标集一致。大多数质量指标与已公布的验证指标集不同,通常与质量的结构维度有关。有必要在欧洲范围内建立一套全面的、可用的、经过验证的核心质量指标,以监测围手术期护理的质量。
{"title":"A survey and analysis of peri-operative quality indicators promoted by National Societies of Anaesthesiologists in Europe: The EQUIP project.","authors":"Johannes Wacker,Guy Haller,Jan F A Hendrickx,Martin Ponschab","doi":"10.1097/eja.0000000000002054","DOIUrl":"https://doi.org/10.1097/eja.0000000000002054","url":null,"abstract":"BACKGROUNDTo capture preventable peri-operative patient harm and guide improvement initiatives, many quality indicators (QIs) have been developed. Several National Anaesthesiologist Societies (NAS) in Europe have implemented quality indicators. To date, the definitions, validity and dissemination of such quality indicators, and their comparability with validated published indicators are unknown.OBJECTIVESThe aim of this study was to identify all quality indicators promoted by NAS in Europe, to assess their characteristics and to compare them with published validated quality indicators.DESIGNA cross-sectional study with mixed methods analysis. Using a survey questionnaire, representatives of 37 NAS were asked if their society provided quality indicators to their members and, if so, to provide the list, definitions and details of quality indicators. Characteristics of reported quality indicators were analysed.SETTINGThe 37 NAS affiliated with the European Society of Anaesthesiology and Intensive Care (ESAIC) at the time. Data collection, translations: March 2018 to February 2020.PARTICIPANTSRepresentatives of all 37 NAS completed the survey.MAIN OUTCOME MEASURESQIs reported by NAS.RESULTSOnly 12 (32%) of the 37 NAS had made a set of quality indicators available to their members. Data collection was mandatory in six (16.2%) of the 37 countries. We identified 163 individual quality indicators, which were most commonly descriptive (60.1%), anaesthesia-specific (50.3%) and related to intra-operative care (21.5%). They often measured structures (41.7%) and aspects of safety (35.6%), appropriateness (20.9%) and prevention (16.6%). Patient-centred care (3.7%) was not well covered. Only 11.7% of QIs corresponded to published validated or well established quality indicator sets.CONCLUSIONSFew NAS in Europe promoted peri-operative quality indicators. Most of them differed from published sets of validated indicators and were often related to the structural dimension of quality. There is a need to establish a European-wide comprehensive core set of usable and validated quality indicators to monitor the quality of peri-operative care.TRIAL REGISTRATIONNo registration.","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":"5 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mean arterial pressure versus cardiac index for haemodynamic management and myocardial injury after hepatopancreatic surgery: A randomised controlled trial. 肝胰腺手术后血流动力学管理和心肌损伤方面的平均动脉压与心脏指数对比:随机对照试验。
IF 3.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-12 DOI: 10.1097/eja.0000000000002059
Taner Abdullah,Hürü Ceren Gökduman,İşbara Alp Enişte,İlyas Kudaş,Achmet Ali,Erdem Kınacı,İlgin Özden,Funda Gümüş Özcan
BACKGROUNDMyocardial injury after noncardiac surgery (MINS) frequently complicates the peri-operative period and is associated with increased mortality.OBJECTIVESWe hypothesised that cardiac index (CI) based haemodynamic management reduces peri-operative high-sensitive troponin-T (hsTnT) elevation and MINS incidence in patients undergoing hepatic/pancreatic surgery compared to mean arterial pressure.DESIGNA randomised controlled study.SETTINGA single-centre study conducted in a university-affiliated tertiary hospital between June 2022 and March 2023.PATIENTSNinety-one patients, who were ≥ 65 years old or ≥ 45 years old with a history of at least one cardiac risk factor were randomised to either mean arterial pressure (MAP) based (n = 45) or CI-based (n = 46) management groups, and completed the study.INTERVENTIONSIn group-MAP, patients received fluid boluses and/or a noradrenaline infusion to maintain MAP above the predefined threshold. In group-CI, patients received fluid boluses and/or dobutamine infusion to keep CI above the predefined threshold. When a low MAP was observed despite a normal CI, a noradrenaline infusion was started.MAIN OUTCOME MEASURESThe primary outcome was peri-operative hsTnT elevation. The secondary outcomes were MINS incidence and 90-day mortality.RESULTSThe median absolute troponin elevation was 4.3 ng l-1 (95% CI 3.4 to 6) for the CI-based group, and 9.4 ng l-1 (95% CI 7.7 to 12.7) for the MAP-based group (median difference: 5.1 ng l-1, 95% CI 3 to 7; P < 0.001). MINS occurred in 8 (17.4%) patients in the CI-based group and 17 (37.8%) patients in the MAP-based group (relative risk: 0.46, 95% CI: 0.22 to 0.96; P = 0.029). Two patients in group-MAP died from cardiovascular-related causes. One patient in group-CI and two in group-MAP died from sepsis-related complications (for all-cause mortality: χ2 = 1.98, P = 0.16). MAP-AUC and CI-AUC values of the CI- and MAP-based groups were 147 vs. 179 min × mmHg (P = 0.85) and 8.4 vs. 43.2 l m-2 min-1 × min (P < 0.001), respectively.CONCLUSIONSCI-based haemodynamic management assures sufficient flow and consequently is associated with peri-operative hsTnT elevation and the incidence of MINS compared to MAP.TRIAL REGISTRATIONClinicaltrials.gov identifier: NCT05391087.
背景非心脏手术后心肌损伤(MINS)经常使围手术期变得复杂,并与死亡率增加有关。目的我们假设,与平均动脉压相比,基于心脏指数(CI)的血流动力学管理可降低肝脏/胰腺手术患者围手术期高敏肌钙蛋白-T(hsTnT)升高和 MINS 发生率。设置2022年6月至2023年3月期间在一所大学附属三级医院进行的单中心研究。患者91名年龄≥65岁或≥45岁且至少有一个心脏风险因素病史的患者被随机分配到基于平均动脉压(MAP)(n = 45)或基于CI(n = 46)的管理组,并完成研究。干预在 MAP 组,患者接受液体注射和/或去甲肾上腺素输注,以将 MAP 维持在预定阈值以上。在 CI 组中,患者接受液体注射和/或多巴酚丁胺输注,以将 CI 维持在预定阈值以上。主要结局测量主要结局是围手术期 hsTnT 升高。结果基于 CI 组的绝对肌钙蛋白升高中位数为 4.3 纳克/升(95% CI 3.4 至 6),基于 MAP 组的绝对肌钙蛋白升高中位数为 9.4 纳克/升(95% CI 7.7 至 12.7)(中位数差异:5.1 纳克/升,95% CI 3 至 7;P < 0.001)。基于 CI 的组别中有 8 名患者(17.4%)发生 MINS,基于 MAP 的组别中有 17 名患者(37.8%)发生 MINS(相对风险:0.46,95% CI:0.22 至 0.96;P = 0.029)。MAP 组中有两名患者死于心血管相关原因。CI组和MAP组分别有一名和两名患者死于脓毒症相关并发症(全因死亡率:χ2 = 1.98,P = 0.16)。结论与 MAP 相比,CI 组和 MAP 组的 MAP-AUC 和 CI-AUC 值分别为 147 vs. 179 min × mmHg(P = 0.85)和 8.4 vs. 43.2 l m-2 min-1 × min(P < 0.001).TRIAL REGISTRATIONClinicaltrials.gov identifier:NCT05391087。
{"title":"Mean arterial pressure versus cardiac index for haemodynamic management and myocardial injury after hepatopancreatic surgery: A randomised controlled trial.","authors":"Taner Abdullah,Hürü Ceren Gökduman,İşbara Alp Enişte,İlyas Kudaş,Achmet Ali,Erdem Kınacı,İlgin Özden,Funda Gümüş Özcan","doi":"10.1097/eja.0000000000002059","DOIUrl":"https://doi.org/10.1097/eja.0000000000002059","url":null,"abstract":"BACKGROUNDMyocardial injury after noncardiac surgery (MINS) frequently complicates the peri-operative period and is associated with increased mortality.OBJECTIVESWe hypothesised that cardiac index (CI) based haemodynamic management reduces peri-operative high-sensitive troponin-T (hsTnT) elevation and MINS incidence in patients undergoing hepatic/pancreatic surgery compared to mean arterial pressure.DESIGNA randomised controlled study.SETTINGA single-centre study conducted in a university-affiliated tertiary hospital between June 2022 and March 2023.PATIENTSNinety-one patients, who were ≥ 65 years old or ≥ 45 years old with a history of at least one cardiac risk factor were randomised to either mean arterial pressure (MAP) based (n = 45) or CI-based (n = 46) management groups, and completed the study.INTERVENTIONSIn group-MAP, patients received fluid boluses and/or a noradrenaline infusion to maintain MAP above the predefined threshold. In group-CI, patients received fluid boluses and/or dobutamine infusion to keep CI above the predefined threshold. When a low MAP was observed despite a normal CI, a noradrenaline infusion was started.MAIN OUTCOME MEASURESThe primary outcome was peri-operative hsTnT elevation. The secondary outcomes were MINS incidence and 90-day mortality.RESULTSThe median absolute troponin elevation was 4.3 ng l-1 (95% CI 3.4 to 6) for the CI-based group, and 9.4 ng l-1 (95% CI 7.7 to 12.7) for the MAP-based group (median difference: 5.1 ng l-1, 95% CI 3 to 7; P < 0.001). MINS occurred in 8 (17.4%) patients in the CI-based group and 17 (37.8%) patients in the MAP-based group (relative risk: 0.46, 95% CI: 0.22 to 0.96; P = 0.029). Two patients in group-MAP died from cardiovascular-related causes. One patient in group-CI and two in group-MAP died from sepsis-related complications (for all-cause mortality: χ2 = 1.98, P = 0.16). MAP-AUC and CI-AUC values of the CI- and MAP-based groups were 147 vs. 179 min × mmHg (P = 0.85) and 8.4 vs. 43.2 l m-2 min-1 × min (P < 0.001), respectively.CONCLUSIONSCI-based haemodynamic management assures sufficient flow and consequently is associated with peri-operative hsTnT elevation and the incidence of MINS compared to MAP.TRIAL REGISTRATIONClinicaltrials.gov identifier: NCT05391087.","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":"63 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142226506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of remimazolam on intra-operative hypotension: Systematic review and meta-analysis of randomised controlled trials. 雷马唑仑对术中低血压的影响:随机对照试验的系统回顾和荟萃分析。
IF 3.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-12 DOI: 10.1097/eja.0000000000002057
Ting-Yu He,Rui-Peng Zhong,Wei-Bo Zhong,Gui-Ming Huang,Xiao-Cheng Liu
BACKGROUNDHypotension is common during anaesthesia. Increasing number of studies have reported that remimazolam may be associated with lower incidence of intra-operative hypotension compared with other anaesthetics. However, the results remain controversial.OBJECTIVEThis study aimed to evaluate the influence of remimazolam on intra-operative hypotension and its related outcomes (hypoxaemia, bradycardia and time to awake).DESIGNA systematic review of randomised controlled trials (RCTs) with meta-analyses.DATA SOURCESPubMed, Cocharane and Embase databases were searched to identify eligible RCTs published up to June 2024.ELIGIBILITY CRITERIARCTs published in English were eligible for inclusion. The study patients were 18 years or older who were administered with remimazolam and other positive control agents in either the pre-operative or intra-operative period. The incidence of intra-operative hypotension was identified in these studies.RESULTSThis study evaluated 34 trials including 4847 individuals. Basing on moderate-certainty evidence, we found that remimazolam administration reduced the incidence of intra-operative hypotension [risk ratio (RR) = 0.48, 95% confidence interval (95% CI): 0.41 to 0.57] and bradycardia (16 studies, n = 2869, RR = 0.40, 95% CI: 0.29 to 0.54). No difference was observed in the incidence of hypoxaemia (RR = 0.70, 95% CI: 0.48 to 1.01) and time to awake (MD = -0.91, 95% CI: -2.42 to 0.60). The remarkable association between remimazolam and hypotension remained robust and significant, regardless of general anaesthesia or procedural sedation (P < 0.01, I2 = 82%). No significant difference was found between different control drugs (P = 0.97, I2 = 82%).CONCLUSIONModerate-quality evidence shows that remimazolam administration to patients undergoing general anaesthesia or procedural sedation decreases the incidence of intra-operative hypotension and bradycardia.
背景麻醉期间低血压很常见。越来越多的研究报告称,与其他麻醉药相比,雷马唑仑可能会降低术中低血压的发生率。本研究旨在评估雷马唑仑对术中低血压及其相关结果(低氧血症、心动过缓和清醒时间)的影响。数据来源检索了PubMed、Cocharane和Embase数据库,以确定截至2024年6月发表的符合条件的RCT。研究对象为18岁或以上的患者,他们在术前或术中均接受了雷马唑仑和其他阳性对照药的治疗。结果本研究评估了 34 项试验,包括 4847 人。根据中度确定性证据,我们发现服用雷马唑仑可降低术中低血压[风险比(RR)= 0.48,95% 置信区间(95% CI):0.41 至 0.57]和心动过缓(16 项研究,n = 2869,RR = 0.40,95% CI:0.29 至 0.54)的发生率。在低氧血症发生率(RR = 0.70,95% CI:0.48 至 1.01)和清醒时间(MD = -0.91,95% CI:-2.42 至 0.60)方面未观察到差异。不管是全身麻醉还是手术镇静,雷马唑仑与低血压之间的明显关联性仍然稳固且显著(P < 0.01,I2 = 82%)。结论中等质量的证据表明,对接受全身麻醉或手术镇静的患者使用雷马唑仑可降低术中低血压和心动过缓的发生率。
{"title":"Effect of remimazolam on intra-operative hypotension: Systematic review and meta-analysis of randomised controlled trials.","authors":"Ting-Yu He,Rui-Peng Zhong,Wei-Bo Zhong,Gui-Ming Huang,Xiao-Cheng Liu","doi":"10.1097/eja.0000000000002057","DOIUrl":"https://doi.org/10.1097/eja.0000000000002057","url":null,"abstract":"BACKGROUNDHypotension is common during anaesthesia. Increasing number of studies have reported that remimazolam may be associated with lower incidence of intra-operative hypotension compared with other anaesthetics. However, the results remain controversial.OBJECTIVEThis study aimed to evaluate the influence of remimazolam on intra-operative hypotension and its related outcomes (hypoxaemia, bradycardia and time to awake).DESIGNA systematic review of randomised controlled trials (RCTs) with meta-analyses.DATA SOURCESPubMed, Cocharane and Embase databases were searched to identify eligible RCTs published up to June 2024.ELIGIBILITY CRITERIARCTs published in English were eligible for inclusion. The study patients were 18 years or older who were administered with remimazolam and other positive control agents in either the pre-operative or intra-operative period. The incidence of intra-operative hypotension was identified in these studies.RESULTSThis study evaluated 34 trials including 4847 individuals. Basing on moderate-certainty evidence, we found that remimazolam administration reduced the incidence of intra-operative hypotension [risk ratio (RR) = 0.48, 95% confidence interval (95% CI): 0.41 to 0.57] and bradycardia (16 studies, n = 2869, RR = 0.40, 95% CI: 0.29 to 0.54). No difference was observed in the incidence of hypoxaemia (RR = 0.70, 95% CI: 0.48 to 1.01) and time to awake (MD = -0.91, 95% CI: -2.42 to 0.60). The remarkable association between remimazolam and hypotension remained robust and significant, regardless of general anaesthesia or procedural sedation (P < 0.01, I2 = 82%). No significant difference was found between different control drugs (P = 0.97, I2 = 82%).CONCLUSIONModerate-quality evidence shows that remimazolam administration to patients undergoing general anaesthesia or procedural sedation decreases the incidence of intra-operative hypotension and bradycardia.","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":"46 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-operative triAge proCedure to streaMline elective surgicAl patieNts (PACMAN) improves efficiency by selecting patients eligible for phone consultation: A retrospective cohort study. 简化择期手术患者的术前三阶段治疗(PACMAN)通过选择符合电话咨询条件的患者来提高效率:一项回顾性队列研究。
IF 3.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-10 DOI: 10.1097/eja.0000000000002055
Manuela Di Biase,Babette van der Zwaard,Fenne Aarts,Barbe Pieters
BACKGROUNDPre-operative screening is a high volume task consuming time and resource. Streamlining patient flow by gathering information in advance reduces costs, optimises resources and diminishes patient burden whilst maintaining safety of care.OBJECTIVETo evaluate whether 'Pre-operative triAge proCedure to streaMline elective surgicAl patieNts' (PACMAN) is able to improve pre-operative screening by selecting patients eligible for evaluation by telephone.DESIGNA single-centre, retrospective, observational cohort analysis.SETTINGA tertiary medical teaching hospital in 's-Hertogenbosch, The Netherlands.PATIENTS AND METHODSAdults scheduled for clinical interventions under procedural sedation and all types of elective medium or low risk surgery with anaesthetic guidance were eligible. Patients answered a questionnaire to calculate the PACMAN score. This score combined with risk factors related to surgery determines suitability for phone consultation (PhC) or the need for an in-person consultation (in-PC).INTERVENTIONEvaluation of standard care.MAIN OUTCOME MEASURESPrimary outcome was the reduction in number of in-PCs. Secondary outcomes included reliability of PACMAN, peri-operative patient outcomes and cost-effectiveness.RESULTSOf 965 patients triaged by PACMAN, 705 (73.1%) were identified as suitable for a PhC. Of those, 688 (97.6%) were classified American Society of Anesthesiologists Physical Status (ASA-PS) I to II or III with stable comorbidities. Of the 260 in-PC patients, 47.4% were classified ASA-PS III with unstable comorbidities or ASA-PS IV. The overall incidence of unanticipated adverse peri-operative events was 1.3%. Finally, implementation of PACMAN led to a 20% increase in pre-operative department efficiency due to better deployment of personnel and resources.CONCLUSIONImplementation of PACMAN resulted in a 73.1% reduction in pre-operative in-PCs at our hospital. Given the increasing pressure on healthcare systems globally, we suggest developing further optimisation and integration of smart triage solutions into the pre-operative process.TRIAL REGISTRATIONClinicalTrials.gov Identifier: NCT06148701.
背景术前筛查是一项耗费时间和资源的大工作量工作。通过提前收集信息来简化患者流程可以降低成本、优化资源、减轻患者负担,同时保证医疗安全。目的评估 "术前三联简化择期手术患者程序"(PACMAN)是否能够通过电话筛选出符合评估条件的患者来改进术前筛查。患者和方法计划在程序性镇静下进行临床干预的成人以及在麻醉指导下进行所有类型的中低风险择期手术的患者均符合条件。患者回答问卷以计算 PACMAN 评分。该评分结合与手术相关的风险因素决定患者是否适合电话咨询(PhC)或是否需要亲自咨询(in-PC)。主要结果测量主要结果是减少了in-PC的次数。次要结果包括 PACMAN 的可靠性、围手术期患者预后和成本效益。结果在 PACMAN 分流的 965 名患者中,有 705 人(73.1%)被确定为适合进行现场会诊。其中,688 人(97.6%)被归类为美国麻醉医师协会身体状况(ASA-PS)I 至 II 级或 III 级,合并症稳定。在 260 名住院患者中,47.4% 被归类为 ASA-PS III 且合并症不稳定或 ASA-PS IV。围手术期意外不良事件的总发生率为 1.3%。最后,由于更好地调配了人员和资源,PACMAN 的实施使术前部门的效率提高了 20%。鉴于全球医疗系统面临的压力越来越大,我们建议进一步优化和整合术前流程中的智能分诊解决方案:NCT06148701。
{"title":"Pre-operative triAge proCedure to streaMline elective surgicAl patieNts (PACMAN) improves efficiency by selecting patients eligible for phone consultation: A retrospective cohort study.","authors":"Manuela Di Biase,Babette van der Zwaard,Fenne Aarts,Barbe Pieters","doi":"10.1097/eja.0000000000002055","DOIUrl":"https://doi.org/10.1097/eja.0000000000002055","url":null,"abstract":"BACKGROUNDPre-operative screening is a high volume task consuming time and resource. Streamlining patient flow by gathering information in advance reduces costs, optimises resources and diminishes patient burden whilst maintaining safety of care.OBJECTIVETo evaluate whether 'Pre-operative triAge proCedure to streaMline elective surgicAl patieNts' (PACMAN) is able to improve pre-operative screening by selecting patients eligible for evaluation by telephone.DESIGNA single-centre, retrospective, observational cohort analysis.SETTINGA tertiary medical teaching hospital in 's-Hertogenbosch, The Netherlands.PATIENTS AND METHODSAdults scheduled for clinical interventions under procedural sedation and all types of elective medium or low risk surgery with anaesthetic guidance were eligible. Patients answered a questionnaire to calculate the PACMAN score. This score combined with risk factors related to surgery determines suitability for phone consultation (PhC) or the need for an in-person consultation (in-PC).INTERVENTIONEvaluation of standard care.MAIN OUTCOME MEASURESPrimary outcome was the reduction in number of in-PCs. Secondary outcomes included reliability of PACMAN, peri-operative patient outcomes and cost-effectiveness.RESULTSOf 965 patients triaged by PACMAN, 705 (73.1%) were identified as suitable for a PhC. Of those, 688 (97.6%) were classified American Society of Anesthesiologists Physical Status (ASA-PS) I to II or III with stable comorbidities. Of the 260 in-PC patients, 47.4% were classified ASA-PS III with unstable comorbidities or ASA-PS IV. The overall incidence of unanticipated adverse peri-operative events was 1.3%. Finally, implementation of PACMAN led to a 20% increase in pre-operative department efficiency due to better deployment of personnel and resources.CONCLUSIONImplementation of PACMAN resulted in a 73.1% reduction in pre-operative in-PCs at our hospital. Given the increasing pressure on healthcare systems globally, we suggest developing further optimisation and integration of smart triage solutions into the pre-operative process.TRIAL REGISTRATIONClinicalTrials.gov Identifier: NCT06148701.","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":"3 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of goal-directed analgesia using the analgesia nociception index in children undergoing surgery for moyamoya disease: A randomised controlled trial. 使用镇痛痛觉指数对接受莫亚莫亚病手术的儿童进行目标导向镇痛的效果:随机对照试验。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-03 DOI: 10.1097/EJA.0000000000002013
Jung-Bin Park, Pyoyoon Kang, Sang-Hwan Ji, Young-Eun Jang, Ji-Hyun Lee, Jin-Tae Kim, Hee-Soo Kim, Eun-Hee Kim

Background: The potential benefits of Analgesia Nociception Index guided intra-operative analgesia on intra-operative opioid consumption remains to be demonstrated in paediatric anaesthesia.

Objectives: This study aimed to explore the effects of Analgesia Nociception Index guided analgesia on sufentanil consumption during anaesthesia and postoperative pain scores in paediatric patients with moyamoya disease.

Design: A prospective randomised controlled study.

Setting: Seoul National University Children's Hospital, Seoul, Republic of Korea.

Patients: A total of 40 children scheduled for encephaloduroarteriosynangiosis.

Main outcome measures: The primary outcome was total intra-operative sufentanil consumption, and the secondary outcomes included postoperative pain scores and incidence of opioid-related adverse events.

Results: The Analgesia Nociception Index group showed lower intra-operative sufentanil consumption (in μg kg -1  h -1 ) compared with the Standard group (0.30 ± 0.12 and 0.39 ± 0.17, respectively; mean difference, -0.09; 95% confidence interval, -0.19 to 0.00; P  = 0.049). Postoperatively, compared with the Standard group, the Analgesia Nociception Index group reported lower median pain scores at 18 and 24 h and maximum pain within 24 h (1 [0 to 2] vs. 3 [2 to 5]; P  = 0.004, 1 [0 to 2] vs. 3 [1 to 4]; P  = 0.041, and 4 [3 to 5] vs. 5 [4 to 7]; P  = 0.045, respectively), with fewer patients experiencing nausea (3 [15%] vs. 10 [50%], P  = 0.043).

Conclusion: The Analgesia Nociception Index guided analgesic protocol can reduce intra-operative sufentanil consumption and postoperative pain within 24 h with fewer nausea symptoms in paediatric patients with moyamoya disease who undergo encephaloduroarteriosynangiosis.

Trial registration number: NCT05672212.

背景:Analgesia Nociception Index(镇痛痛觉指数)指导下的术中镇痛对术中阿片类药物消耗的潜在益处在儿科麻醉中仍有待证实:本研究旨在探讨 Analgesia Nociception Index(镇痛痛觉指数)指导下的镇痛对 moyamoya 病儿科患者麻醉期间舒芬太尼用量和术后疼痛评分的影响:前瞻性随机对照研究:地点:大韩民国首尔,首尔国立大学儿童医院:主要结果指标:主要结果:术中舒芬太尼总用量为主要结果,次要结果包括术后疼痛评分和阿片类药物相关不良事件的发生率:结果:与标准组相比,镇痛痛觉指数组的术中舒芬太尼消耗量(单位:μg kg-1 h-1)更低(分别为 0.30 ± 0.12 和 0.39 ± 0.17;平均差异,-0.09;95% 置信区间,-0.19 至 0.00;P = 0.049)。术后,与标准组相比,镇痛痛觉指数组在 18 和 24 小时内的中位疼痛评分和 24 小时内的最大疼痛评分较低(1 [0 至 2] vs. 3 [2 至 5];P = 0.004, 1 [0 to 2] vs. 3 [1 to 4]; P = 0.041, and 4 [3 to 5] vs. 5 [4 to 7]; P = 0.045, respectively),出现恶心的患者较少(3 [15%] vs. 10 [50%], P = 0.043):镇痛痛觉指数指导镇痛方案可减少术中舒芬太尼的用量,并在24小时内减轻接受脑室动脉神经节栓塞术的moyamoya病儿科患者的术后疼痛,同时减少恶心症状:试验注册号:NCT05672212(注册于 clinicaltrials,主要研究者:K.E.H.,注册号:NCT05672212):试验注册号:NCT05672212(注册于 clinicaltrials,主要研究者:K.E.H.,注册日期:2023年1月2日)。
{"title":"Effects of goal-directed analgesia using the analgesia nociception index in children undergoing surgery for moyamoya disease: A randomised controlled trial.","authors":"Jung-Bin Park, Pyoyoon Kang, Sang-Hwan Ji, Young-Eun Jang, Ji-Hyun Lee, Jin-Tae Kim, Hee-Soo Kim, Eun-Hee Kim","doi":"10.1097/EJA.0000000000002013","DOIUrl":"10.1097/EJA.0000000000002013","url":null,"abstract":"<p><strong>Background: </strong>The potential benefits of Analgesia Nociception Index guided intra-operative analgesia on intra-operative opioid consumption remains to be demonstrated in paediatric anaesthesia.</p><p><strong>Objectives: </strong>This study aimed to explore the effects of Analgesia Nociception Index guided analgesia on sufentanil consumption during anaesthesia and postoperative pain scores in paediatric patients with moyamoya disease.</p><p><strong>Design: </strong>A prospective randomised controlled study.</p><p><strong>Setting: </strong>Seoul National University Children's Hospital, Seoul, Republic of Korea.</p><p><strong>Patients: </strong>A total of 40 children scheduled for encephaloduroarteriosynangiosis.</p><p><strong>Main outcome measures: </strong>The primary outcome was total intra-operative sufentanil consumption, and the secondary outcomes included postoperative pain scores and incidence of opioid-related adverse events.</p><p><strong>Results: </strong>The Analgesia Nociception Index group showed lower intra-operative sufentanil consumption (in μg kg -1  h -1 ) compared with the Standard group (0.30 ± 0.12 and 0.39 ± 0.17, respectively; mean difference, -0.09; 95% confidence interval, -0.19 to 0.00; P  = 0.049). Postoperatively, compared with the Standard group, the Analgesia Nociception Index group reported lower median pain scores at 18 and 24 h and maximum pain within 24 h (1 [0 to 2] vs. 3 [2 to 5]; P  = 0.004, 1 [0 to 2] vs. 3 [1 to 4]; P  = 0.041, and 4 [3 to 5] vs. 5 [4 to 7]; P  = 0.045, respectively), with fewer patients experiencing nausea (3 [15%] vs. 10 [50%], P  = 0.043).</p><p><strong>Conclusion: </strong>The Analgesia Nociception Index guided analgesic protocol can reduce intra-operative sufentanil consumption and postoperative pain within 24 h with fewer nausea symptoms in paediatric patients with moyamoya disease who undergo encephaloduroarteriosynangiosis.</p><p><strong>Trial registration number: </strong>NCT05672212.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":"649-656"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of nitric oxide delivery via cardiopulmonary bypass circuit on postoperative oxygenation in adults undergoing cardiac surgery (NOCARD trial): a randomised controlled trial. 通过心肺旁路回路输送一氧化氮对成人心脏手术术后氧合的影响(NOCARD 试验):随机对照试验。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-28 DOI: 10.1097/EJA.0000000000002022
Karam Azem, Denis Novakovsky, Boris Krasulya, Shai Fein, Daniel Iluz-Freundlich, Julia Uhanova, Evgeniya Kornilov, Leonid A Eidelman, Shani Kaptzon, Dan Gorfil, Dan Aravot, Yaron Barac, Roussana Aranbitski

Background: Cardiac surgery involving cardiopulmonary bypass induces a significant systemic inflammatory response, contributing to various postoperative complications, including pulmonary dysfunction, myocardial and kidney injuries.

Objective: To investigate the effect of Nitric Oxide delivery via the cardiopulmonary bypass circuit on various postoperative outcomes.

Design: A prospective, single-centre, double-blinded, randomised controlled trial.

Setting: Rabin Medical Centre, Beilinson Hospital, Israel.

Patients: Adult patients scheduled for elective cardiac surgery were randomly allocated to one of the study groups.

Interventions: For the treatment group, 40 ppm of nitric oxide was delivered via the cardiopulmonary bypass circuit. For the control group, nitric oxide was not delivered.

Outcome measures: The primary outcome was the incidence of hypoxaemia, defined as a p a O2 /FiO 2 ratio less than 300 within 24 h postoperatively. The secondary outcomes were the incidences of low cardiac output syndrome and acute kidney injury within 72 h postoperatively.

Results: Ninety-eight patients were included in the final analysis, with 47 patients allocated to the control group and 51 to the Nitric Oxide group. The Nitric Oxide group exhibited significantly lower hypoxaemia rates at admission to the cardiothoracic intensive care unit (47.1 vs. 68.1%), P  = 0.043. This effect, however, varied in patients with or without baseline hypoxaemia. Patients with baseline hypoxaemia who received nitric oxide exhibited significantly lower hypoxaemia rates (61.1 vs. 93.8%), P  = 0.042, and higher p a O2 /FiO 2 ratios at all time points, F (1,30) = 6.08, P  = 0.019. Conversely, this benefit was not observed in patients without baseline hypoxaemia. No significant differences were observed in the incidence of low cardiac output syndrome or acute kidney injury. No substantial safety concerns were noted, and toxic methaemoglobin levels were not observed.

Conclusions: Patients with baseline hypoxaemia undergoing cardiac surgery and receiving nitric oxide exhibited lower hypoxaemia rates and higher p a O2 /FiO 2 ratios. No significant differences were found regarding postoperative pulmonary complications and overall outcomes.

Trial registration: NCT04807413.

背景:涉及心肺旁路的心脏手术会引起明显的全身炎症反应,导致各种术后并发症,包括肺功能障碍、心肌和肾损伤:研究通过心肺旁路回路输送一氧化氮对各种术后结果的影响:前瞻性、单中心、双盲、随机对照试验:地点:以色列贝林森医院拉宾医疗中心:患者:计划接受择期心脏手术的成人患者,随机分配到其中一个研究组:治疗组:通过心肺旁路回路输送 40 ppm 的一氧化氮。结果测量:主要结果是低氧血症的发生率,即术后 24 小时内 paO2/FiO2 比率低于 300。次要结果是术后 72 小时内低心排血量综合征和急性肾损伤的发生率:98名患者被纳入最终分析,其中47名患者被分配到对照组,51名患者被分配到一氧化氮组。一氧化氮组患者入住心胸重症监护室时的低氧血症率明显降低(47.1% 对 68.1%),P = 0.043。然而,这一效果在基线低氧血症或无基线低氧血症的患者中有所不同。基线低氧血症患者接受一氧化氮治疗后,低氧血症发生率明显降低(61.1% 对 93.8%),P = 0.042;在所有时间点,paO2/FiO2 比值均较高,F (1,30) = 6.08,P = 0.019。相反,在没有基线低氧血症的患者中没有观察到这种益处。在低心排出量综合征或急性肾损伤的发生率方面没有观察到明显差异。未发现重大安全问题,也未观察到毒性高铁血红蛋白水平:结论:接受心脏手术的基线低氧血症患者接受一氧化氮治疗后,低氧血症发生率较低,paO2/FiO2 比率较高。在术后肺部并发症和总体预后方面没有发现明显差异:本试验已在 ClinicalTrials.gov (NCT04807413) 上注册。
{"title":"Effect of nitric oxide delivery via cardiopulmonary bypass circuit on postoperative oxygenation in adults undergoing cardiac surgery (NOCARD trial): a randomised controlled trial.","authors":"Karam Azem, Denis Novakovsky, Boris Krasulya, Shai Fein, Daniel Iluz-Freundlich, Julia Uhanova, Evgeniya Kornilov, Leonid A Eidelman, Shani Kaptzon, Dan Gorfil, Dan Aravot, Yaron Barac, Roussana Aranbitski","doi":"10.1097/EJA.0000000000002022","DOIUrl":"10.1097/EJA.0000000000002022","url":null,"abstract":"<p><strong>Background: </strong>Cardiac surgery involving cardiopulmonary bypass induces a significant systemic inflammatory response, contributing to various postoperative complications, including pulmonary dysfunction, myocardial and kidney injuries.</p><p><strong>Objective: </strong>To investigate the effect of Nitric Oxide delivery via the cardiopulmonary bypass circuit on various postoperative outcomes.</p><p><strong>Design: </strong>A prospective, single-centre, double-blinded, randomised controlled trial.</p><p><strong>Setting: </strong>Rabin Medical Centre, Beilinson Hospital, Israel.</p><p><strong>Patients: </strong>Adult patients scheduled for elective cardiac surgery were randomly allocated to one of the study groups.</p><p><strong>Interventions: </strong>For the treatment group, 40 ppm of nitric oxide was delivered via the cardiopulmonary bypass circuit. For the control group, nitric oxide was not delivered.</p><p><strong>Outcome measures: </strong>The primary outcome was the incidence of hypoxaemia, defined as a p a O2 /FiO 2 ratio less than 300 within 24 h postoperatively. The secondary outcomes were the incidences of low cardiac output syndrome and acute kidney injury within 72 h postoperatively.</p><p><strong>Results: </strong>Ninety-eight patients were included in the final analysis, with 47 patients allocated to the control group and 51 to the Nitric Oxide group. The Nitric Oxide group exhibited significantly lower hypoxaemia rates at admission to the cardiothoracic intensive care unit (47.1 vs. 68.1%), P  = 0.043. This effect, however, varied in patients with or without baseline hypoxaemia. Patients with baseline hypoxaemia who received nitric oxide exhibited significantly lower hypoxaemia rates (61.1 vs. 93.8%), P  = 0.042, and higher p a O2 /FiO 2 ratios at all time points, F (1,30) = 6.08, P  = 0.019. Conversely, this benefit was not observed in patients without baseline hypoxaemia. No significant differences were observed in the incidence of low cardiac output syndrome or acute kidney injury. No substantial safety concerns were noted, and toxic methaemoglobin levels were not observed.</p><p><strong>Conclusions: </strong>Patients with baseline hypoxaemia undergoing cardiac surgery and receiving nitric oxide exhibited lower hypoxaemia rates and higher p a O2 /FiO 2 ratios. No significant differences were found regarding postoperative pulmonary complications and overall outcomes.</p><p><strong>Trial registration: </strong>NCT04807413.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":"677-686"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141733765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxygen reserve index versus conventional peripheral oxygen saturation for prevention of hypoxaemia: A randomised controlled trial. 氧储备指数与传统外周血氧饱和度在预防低氧血症方面的比较:随机对照试验。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-27 DOI: 10.1097/EJA.0000000000002018
Eun-Hee Kim, Jung-Bin Park, Pyoyoon Kang, Sang-Hwan Ji, Young-Eun Jang, Ji-Hyun Lee, Hee-Soo Kim, Jin-Tae Kim

Background: Hypoxaemia occurs frequently during paediatric laryngeal microsurgery.

Objective: The oxygen reserve index is a noninvasive and continuous parameter to assess PaO2 levels in the range of 100 to 200 mmHg. It ranges from 0 to 1.0. We investigated whether monitoring the oxygen reserve index can reduce the incidence of SpO2 90% or less.

Design: Randomised controlled trial.

Setting: A tertiary care paediatric hospital.

Participants: Paediatric patients aged 18 years or less scheduled to undergo laryngeal microsurgery.

Intervention: The patients were randomly allocated to the oxygen reserve index or control groups, and stratified based on the presence of a tracheostomy tube. Rescue intervention was performed when the oxygen reserve index was 0.2 or less and the SpO2 was 94% or less in the oxygen reserve index and control groups, respectively.

Main outcome measure: The primary outcome was the incidence of SpO2 90% or less during the surgery.

Results: Data from 88 patients were analysed. The incidence of SpO2 ≤ 90% did not differ between the oxygen reserve index and control groups [P = 0.114; 11/44, 25% vs. 18/44, 40.9%; relative risk: 1.27; and 95% confidence interval (CI): 0.94 to 1.72]. Among the 128 rescue interventions, SpO2 ≤ 90% event developed in 18 out of 75 events (24%) and 42 out of 53 events (79.2%) in the oxygen reserve index and control groups, respectively (P < 0.001; difference: 55.2%; and 95% CI 38.5 to 67.2%). The number of SpO2 ≤ 90% events per patient in the oxygen reserve index group (median 0, maximum 3) was less than that in the control group (median 0, maximum 8, P = 0.031).

Conclusion: Additional monitoring of the oxygen reserve index, with a target value of greater than 0.2 during paediatric airway surgery, alongside peripheral oxygen saturation, did not reduce the incidence of SpO2 ≤ 90%.

背景:小儿喉显微手术过程中经常出现低氧血症:小儿喉显微手术过程中经常出现低氧血症:氧储备指数是一个无创和连续的参数,用于评估 100 至 200 mmHg 范围内的 PaO2 水平。其范围为 0 至 1.0。我们研究了监测氧储备指数是否能降低 SpO2 90% 或更低的发生率:随机对照试验:参与者:18 岁或以下的儿科患者:干预措施:将患者随机分配到氧储备指数组或对照组,并根据是否存在气管造口管进行分层。氧储备指数组和对照组分别在氧储备指数为 0.2 或更低和 SpO2 为 94% 或更低时进行抢救干预:结果:分析了 88 名患者的数据。氧储备指数组和对照组之间 SpO2 ≤ 90% 的发生率没有差异 [P = 0.114;11/44,25% 对 18/44,40.9%;相对风险:1.27;95% 置信区间 (CI):0.94 至 1.72]。在 128 例抢救干预中,氧储备指数组和对照组的 75 例事件中分别有 18 例(24%)和 53 例事件中分别有 42 例(79.2%)发生 SpO2 ≤ 90% 的事件(P 结论:SpO2 ≤ 90% 的事件在抢救干预中的发生率较高:在儿科气道手术期间,在监测外周血氧饱和度的同时额外监测氧储备指数(目标值大于 0.2)并不能降低 SpO2 ≤ 90% 的发生率。
{"title":"Oxygen reserve index versus conventional peripheral oxygen saturation for prevention of hypoxaemia: A randomised controlled trial.","authors":"Eun-Hee Kim, Jung-Bin Park, Pyoyoon Kang, Sang-Hwan Ji, Young-Eun Jang, Ji-Hyun Lee, Hee-Soo Kim, Jin-Tae Kim","doi":"10.1097/EJA.0000000000002018","DOIUrl":"https://doi.org/10.1097/EJA.0000000000002018","url":null,"abstract":"<p><strong>Background: </strong>Hypoxaemia occurs frequently during paediatric laryngeal microsurgery.</p><p><strong>Objective: </strong>The oxygen reserve index is a noninvasive and continuous parameter to assess PaO2 levels in the range of 100 to 200 mmHg. It ranges from 0 to 1.0. We investigated whether monitoring the oxygen reserve index can reduce the incidence of SpO2 90% or less.</p><p><strong>Design: </strong>Randomised controlled trial.</p><p><strong>Setting: </strong>A tertiary care paediatric hospital.</p><p><strong>Participants: </strong>Paediatric patients aged 18 years or less scheduled to undergo laryngeal microsurgery.</p><p><strong>Intervention: </strong>The patients were randomly allocated to the oxygen reserve index or control groups, and stratified based on the presence of a tracheostomy tube. Rescue intervention was performed when the oxygen reserve index was 0.2 or less and the SpO2 was 94% or less in the oxygen reserve index and control groups, respectively.</p><p><strong>Main outcome measure: </strong>The primary outcome was the incidence of SpO2 90% or less during the surgery.</p><p><strong>Results: </strong>Data from 88 patients were analysed. The incidence of SpO2 ≤ 90% did not differ between the oxygen reserve index and control groups [P = 0.114; 11/44, 25% vs. 18/44, 40.9%; relative risk: 1.27; and 95% confidence interval (CI): 0.94 to 1.72]. Among the 128 rescue interventions, SpO2 ≤ 90% event developed in 18 out of 75 events (24%) and 42 out of 53 events (79.2%) in the oxygen reserve index and control groups, respectively (P < 0.001; difference: 55.2%; and 95% CI 38.5 to 67.2%). The number of SpO2 ≤ 90% events per patient in the oxygen reserve index group (median 0, maximum 3) was less than that in the control group (median 0, maximum 8, P = 0.031).</p><p><strong>Conclusion: </strong>Additional monitoring of the oxygen reserve index, with a target value of greater than 0.2 during paediatric airway surgery, alongside peripheral oxygen saturation, did not reduce the incidence of SpO2 ≤ 90%.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":"41 9","pages":"687-694"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early supraglottic airway versus facemask ventilation before tracheal intubation to facilitate ventilation in high-risk patients: A prospective randomised trial. 气管插管前尽早使用声门上气道与面罩通气以促进高危患者的通气:前瞻性随机试验。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-01 DOI: 10.1097/EJA.0000000000002030
J Ross Renew, Eslam A Fouda, Dylan M Mordecai, Ashley N Huxhold, Ilana I Logvinov, Michael G Heckman, Klaus D Torp
{"title":"Early supraglottic airway versus facemask ventilation before tracheal intubation to facilitate ventilation in high-risk patients: A prospective randomised trial.","authors":"J Ross Renew, Eslam A Fouda, Dylan M Mordecai, Ashley N Huxhold, Ilana I Logvinov, Michael G Heckman, Klaus D Torp","doi":"10.1097/EJA.0000000000002030","DOIUrl":"10.1097/EJA.0000000000002030","url":null,"abstract":"","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":"707-711"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis and assessment of the predictive value of severity scores in paediatric abdominal trauma: A French national cohort study. 儿科腹部创伤的预后和严重程度评分的预测价值评估:法国全国队列研究。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-20 DOI: 10.1097/EJA.0000000000002019
Sidonie Hanna, Juliette Montmayeur, Estelle Vergnaud, Gilles Orliaguet

Background: Paediatric closed abdominal trauma is common, however, its severity and influence on survival are difficult to determine. No prognostic score integrating abdominal involvement exists to date in paediatrics.

Objectives: To evaluate the severity and short-term and medium-term prognosis of closed abdominal trauma in children, and the performance of severity scores in predicting mortality.

Design: Retrospective, cohort, observational study.

Setting and participants: Patients aged 0 to 18 years presenting at the trauma room of a French paediatric Level I Trauma Centre over the period 2015 to 2019 with an isolated closed abdominal trauma or as part of a polytrauma.

Main outcomes: Primary outcome was the six months mortality. Secondary outcomes were related complications and therapeutic interventions, and performance for predicting mortality of the scores listed. Paediatric Trauma Score (PTS), Revised Trauma Score (RTS), Shock Index Paediatric Age-adjusted (SIPA) score, Reverse shock index multiplied by Glasgow Coma Scale score (rSIG), Base Deficit, International Normalised Ratio, and Glasgow Coma Scale (BIG), Injury Severity Score (ISS) and Trauma Score and the Injury Severity (TRISS) score.

Data collection: Data collected include clinical, biological and CT scan data at admission, first 24 h management and prognosis. The PTS, RTS, SIPA, rSIG, BIG and ISS scores were calculated and mortality was predicted according to BIG score and TRISS methodology.

Results: Of 1145 patients, 149 met the inclusion criteria and 12 (8.1%) died. Of the 12 deceased patients, 11 (91.7%) presented with severe head injury, 11 (91.7%) had blood products transfusion and 7 received tranexamic acid. ROC curves analysis concluded that PTS, RTS, rSIG and BIG scores accurately predict mortality in paediatric closed abdominal trauma with AUCs at least 0.92. The BIG score offered the best predictive performance for predicting mortality at a threshold of 24.8 [sensitivity 90%, specificity 92%, negative-predictive value (NPV) 99%, area under the curve (AUC) 0.93].

Conclusion: PEVALPED is the first French study to evaluate the prognosis of paediatric closed abdominal trauma. The use of PTS, rSIG and BIG scores are relevant from the acute phase and the pathophysiological interest and accuracy of the BIG score make it a powerful tool for predicting mortality of closed abdominal trauma in children.

背景:小儿闭合性腹部创伤很常见,但其严重程度和对存活率的影响却很难确定。迄今为止,儿科尚无综合腹部受累情况的预后评分:评估儿童闭合性腹部创伤的严重程度、短期和中期预后,以及严重程度评分在预测死亡率方面的表现:设计:回顾性、队列、观察性研究:2015年至2019年期间,在法国儿科一级创伤中心创伤室就诊的0至18岁患者,这些患者有的是单独的闭合性腹部创伤,有的是多发性创伤的一部分:主要结果:主要结果是6个月的死亡率。次要结果为相关并发症和治疗干预,以及所列评分预测死亡率的性能。儿科创伤评分(PTS)、修订创伤评分(RTS)、儿科年龄调整后休克指数(SIPA)评分、反向休克指数乘以格拉斯哥昏迷量表评分(rSIG)、基础缺损、国际正常化比率、格拉斯哥昏迷量表(BIG)、损伤严重程度评分(ISS)、创伤评分和损伤严重程度(TRISS)评分:收集的数据包括入院时的临床、生物学和 CT 扫描数据、最初 24 小时的管理和预后。根据 BIG 评分和 TRISS 方法计算 PTS、RTS、SIPA、rSIG、BIG 和 ISS 评分,并预测死亡率:在 1145 名患者中,149 人符合纳入标准,12 人(8.1%)死亡。在这 12 名死亡患者中,11 人(91.7%)有严重颅脑损伤,11 人(91.7%)输了血制品,7 人接受了氨甲环酸治疗。ROC 曲线分析认为,PTS、RTS、rSIG 和 BIG 评分能准确预测儿科闭合性腹部创伤的死亡率,AUC 至少为 0.92。在阈值为 24.8 时,BIG 评分对死亡率的预测效果最佳[灵敏度为 90%,特异度为 92%,负预测值(NPV)为 99%,曲线下面积(AUC)为 0.93]:PEVALPED是法国第一项评估儿科闭合性腹部创伤预后的研究。PTS、rSIG 和 BIG 评分的使用与急性期相关,BIG 评分的病理生理学意义和准确性使其成为预测儿童闭合性腹部创伤死亡率的有力工具。
{"title":"Prognosis and assessment of the predictive value of severity scores in paediatric abdominal trauma: A French national cohort study.","authors":"Sidonie Hanna, Juliette Montmayeur, Estelle Vergnaud, Gilles Orliaguet","doi":"10.1097/EJA.0000000000002019","DOIUrl":"10.1097/EJA.0000000000002019","url":null,"abstract":"<p><strong>Background: </strong>Paediatric closed abdominal trauma is common, however, its severity and influence on survival are difficult to determine. No prognostic score integrating abdominal involvement exists to date in paediatrics.</p><p><strong>Objectives: </strong>To evaluate the severity and short-term and medium-term prognosis of closed abdominal trauma in children, and the performance of severity scores in predicting mortality.</p><p><strong>Design: </strong>Retrospective, cohort, observational study.</p><p><strong>Setting and participants: </strong>Patients aged 0 to 18 years presenting at the trauma room of a French paediatric Level I Trauma Centre over the period 2015 to 2019 with an isolated closed abdominal trauma or as part of a polytrauma.</p><p><strong>Main outcomes: </strong>Primary outcome was the six months mortality. Secondary outcomes were related complications and therapeutic interventions, and performance for predicting mortality of the scores listed. Paediatric Trauma Score (PTS), Revised Trauma Score (RTS), Shock Index Paediatric Age-adjusted (SIPA) score, Reverse shock index multiplied by Glasgow Coma Scale score (rSIG), Base Deficit, International Normalised Ratio, and Glasgow Coma Scale (BIG), Injury Severity Score (ISS) and Trauma Score and the Injury Severity (TRISS) score.</p><p><strong>Data collection: </strong>Data collected include clinical, biological and CT scan data at admission, first 24 h management and prognosis. The PTS, RTS, SIPA, rSIG, BIG and ISS scores were calculated and mortality was predicted according to BIG score and TRISS methodology.</p><p><strong>Results: </strong>Of 1145 patients, 149 met the inclusion criteria and 12 (8.1%) died. Of the 12 deceased patients, 11 (91.7%) presented with severe head injury, 11 (91.7%) had blood products transfusion and 7 received tranexamic acid. ROC curves analysis concluded that PTS, RTS, rSIG and BIG scores accurately predict mortality in paediatric closed abdominal trauma with AUCs at least 0.92. The BIG score offered the best predictive performance for predicting mortality at a threshold of 24.8 [sensitivity 90%, specificity 92%, negative-predictive value (NPV) 99%, area under the curve (AUC) 0.93].</p><p><strong>Conclusion: </strong>PEVALPED is the first French study to evaluate the prognosis of paediatric closed abdominal trauma. The use of PTS, rSIG and BIG scores are relevant from the acute phase and the pathophysiological interest and accuracy of the BIG score make it a powerful tool for predicting mortality of closed abdominal trauma in children.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":"632-640"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141069742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors affecting adherence to recommendations on pre-operative cardiac testing: A cohort study. 影响遵守术前心脏检查建议的因素:一项队列研究。
IF 4.2 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-10 DOI: 10.1097/EJA.0000000000002039
Alexandra Stroda, Tanja Sulot, Sebastian Roth, René M'Pembele, Eckhard Mauermann, Daniela Ionescu, Wojciech Szczeklik, Stefan De Hert, Miodrag Filipovic, Beatrice Beck Schimmer, Savino Spadaro, Purificación Matute, Sanem Cakar Turhan, Judith van Waes, Filipa Lagarto, Kassiani Theodoraki, Anil Gupta, Hans-Jörg Gillmann, Luca Guzzetti, Katarzyna Kotfis, Jan Larmann, Dan Corneci, Simon J Howell, Giovanna Lurati Buse

Background: Cardiac risk evaluation prior to noncardiac surgery is fundamental to tailor peri-operative management to patient's estimated risk. Data on the degree of adherence to guidelines in patients at cardiovascular risk in Europe and factors influencing adherence are underexplored.

Objectives: The aim of this analysis was to describe the degree of adherence to [2014 European Society of Cardiology (ESC)/European Society of Anaesthesiology (ESA) guidelines] recommendations on rest echocardiography [transthoracic echocardiography (TTE)] and to stress imaging prior to noncardiac surgery in a large European sample and to assess factors potentially affecting adherence.

Design: Secondary analysis of a multicentre, international, prospective cohort study (MET-REPAIR).

Setting: Twenty-five European centres of all levels of care that enrolled patients between 2017 and 2020.

Patients: With elevated cardiovascular risk undergoing in-hospital elective, noncardiac surgery.

Main outcome measures: (Non)adherence to each pre-operative TTE and stress imaging recommendations classified as guideline-adherent, overuse and underuse. We performed descriptive analysis. To explore the impact of patients' sex, age, geographical region, and hospital teaching status, we conducted multivariate multinominal regression analysis.

Results: Out of 15 983 patients, 15 529 were analysed (61% men, mean age 72 ± 8 years). Overuse (conduction in spite of class III) and underuse (nonconduction in spite of class I recommendation) for pre-operative TTE amounted to 16.6% (2542/15 344) and 6.6% (1015/15 344), respectively. Stress imaging overuse and underuse amounted to 1.7% (241/14 202) and 0.4% (52/14 202) respectively. Male sex, some age categories and some geographical regions were significantly associated with TTE overuse. Male sex and some regions were also associated with TTE underuse. Age and regions were associated with overuse of stress imaging. Male sex, age, and some regions were associated with stress imaging underuse.

Conclusion: Adherence to pre-operative stress imaging recommendation was high. In contrast, adherence to TTE recommendations was moderate. Both patients' and geographical factors affected adherence to joint ESC/ESA guidelines.

Trial registration: NCT03016936.

背景:非心脏手术前的心脏风险评估是根据患者的估计风险调整围手术期管理的基础。有关欧洲心血管风险患者遵守指南的程度以及影响遵守指南的因素的数据尚未得到充分探讨:本分析旨在描述欧洲大样本非心脏手术前对[2014 年欧洲心脏病学会 (ESC)/ 欧洲麻醉学会 (ESA) 指南]关于静息超声心动图[经胸超声心动图 (TTE)]和负荷成像建议的遵循程度,并评估可能影响遵循程度的因素:对一项多中心、国际性、前瞻性队列研究(MET-REPAIR)进行二次分析:25个欧洲各级医疗中心,在2017年至2020年间招募患者:主要结果测量指标:(对每项术前 TTE 和压力成像建议的(不)遵守情况,分为遵守指南、过度使用和使用不足。我们进行了描述性分析。为了探讨患者性别、年龄、地理区域和医院教学状况的影响,我们进行了多变量多项式回归分析:在 15 983 名患者中,有 15 529 人接受了分析(61% 为男性,平均年龄为 72 ± 8 岁)。术前 TTE 的过度使用(尽管达到 III 级,但仍有导通性)和使用不足(尽管达到 I 级,但仍无导通性)分别占 16.6%(2542/15 344)和 6.6%(1015/15 344)。压力成像过度使用和使用不足的比例分别为 1.7%(241/14 202)和 0.4%(52/14 202)。男性性别、某些年龄段和某些地理区域与 TTE 过度使用明显相关。男性性别和某些地区也与 TTE 使用不足有关。年龄和地区与压力成像过度使用有关。男性性别、年龄和某些地区与压力成像使用不足有关:结论:对术前压力成像建议的依从性很高。结论:对术前压力成像建议的依从性较高,而对 TTE 建议的依从性一般。患者和地理因素都会影响ESC/ESA联合指南的遵循情况:试验注册:Clinicaltrials.gov identifier:试验注册:Clinicaltrials.gov identifier:NCT03016936。
{"title":"Factors affecting adherence to recommendations on pre-operative cardiac testing: A cohort study.","authors":"Alexandra Stroda, Tanja Sulot, Sebastian Roth, René M'Pembele, Eckhard Mauermann, Daniela Ionescu, Wojciech Szczeklik, Stefan De Hert, Miodrag Filipovic, Beatrice Beck Schimmer, Savino Spadaro, Purificación Matute, Sanem Cakar Turhan, Judith van Waes, Filipa Lagarto, Kassiani Theodoraki, Anil Gupta, Hans-Jörg Gillmann, Luca Guzzetti, Katarzyna Kotfis, Jan Larmann, Dan Corneci, Simon J Howell, Giovanna Lurati Buse","doi":"10.1097/EJA.0000000000002039","DOIUrl":"10.1097/EJA.0000000000002039","url":null,"abstract":"<p><strong>Background: </strong>Cardiac risk evaluation prior to noncardiac surgery is fundamental to tailor peri-operative management to patient's estimated risk. Data on the degree of adherence to guidelines in patients at cardiovascular risk in Europe and factors influencing adherence are underexplored.</p><p><strong>Objectives: </strong>The aim of this analysis was to describe the degree of adherence to [2014 European Society of Cardiology (ESC)/European Society of Anaesthesiology (ESA) guidelines] recommendations on rest echocardiography [transthoracic echocardiography (TTE)] and to stress imaging prior to noncardiac surgery in a large European sample and to assess factors potentially affecting adherence.</p><p><strong>Design: </strong>Secondary analysis of a multicentre, international, prospective cohort study (MET-REPAIR).</p><p><strong>Setting: </strong>Twenty-five European centres of all levels of care that enrolled patients between 2017 and 2020.</p><p><strong>Patients: </strong>With elevated cardiovascular risk undergoing in-hospital elective, noncardiac surgery.</p><p><strong>Main outcome measures: </strong>(Non)adherence to each pre-operative TTE and stress imaging recommendations classified as guideline-adherent, overuse and underuse. We performed descriptive analysis. To explore the impact of patients' sex, age, geographical region, and hospital teaching status, we conducted multivariate multinominal regression analysis.</p><p><strong>Results: </strong>Out of 15 983 patients, 15 529 were analysed (61% men, mean age 72 ± 8 years). Overuse (conduction in spite of class III) and underuse (nonconduction in spite of class I recommendation) for pre-operative TTE amounted to 16.6% (2542/15 344) and 6.6% (1015/15 344), respectively. Stress imaging overuse and underuse amounted to 1.7% (241/14 202) and 0.4% (52/14 202) respectively. Male sex, some age categories and some geographical regions were significantly associated with TTE overuse. Male sex and some regions were also associated with TTE underuse. Age and regions were associated with overuse of stress imaging. Male sex, age, and some regions were associated with stress imaging underuse.</p><p><strong>Conclusion: </strong>Adherence to pre-operative stress imaging recommendation was high. In contrast, adherence to TTE recommendations was moderate. Both patients' and geographical factors affected adherence to joint ESC/ESA guidelines.</p><p><strong>Trial registration: </strong>NCT03016936.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":"695-704"},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Anaesthesiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1